Mass Tort Lawsuits Pre-Settlement Legal Funding

If you are one of the thousands of people in one of the many mass tort lawsuits but need cash now, Signal may help with a legal funding.

Mass tort lawsuits usually drag on for a long time simply because they are complex and there are usually hundreds if not thousands of plaintiffs involved, not to mention the dozens of lawyers. However, as a plaintiff in one of these cases, you don’t have to wait for your settlement to be able to access some of that cash today. Call us for legal funding, and we may be able to get you the cash you need as soon as today!

 

A mass tort is simply the legal term that describes a lawsuit involving many plaintiffs, represented by as many attorneys, all fighting a case against a single defendant, usually a company that has produced a faulty product or drug. The most common mass torts today are:

 

  • Transvaginal Mesh
  • IVC Filter
  • Xarelto
  • Risperdal
  • Invokana
  • Morcellator
  • Zofran
  • Stryker and other hip implants
  • Talc
  • FLQs (fluoroquinolone antibacterial drugs)

 

People who have been injured by any one of these products and are currently in a lawsuit to obtain a financial settlement award, don’t have to wait until their lawsuit settles to benefit from some of that money sooner. Signal can offer you a portion of your expected award, usually 10% to 15% of the final award, before your lawsuit is finalized. That’s right. It’s called legal funding.

 

Legal funding from Signal is a non-recourse, no-risk transaction, where we will buy a portion of your future settlement, so you can enjoy some of that cash today. It is no-risk because if you lose your case, you do not pay us back. There are no monthly payments, no up-front fees, no restrictions on the use of the funds you receive, no background checks, and the application is free.

 

To find out more or to apply today for legal funding simply complete the application, or call us direct at 1-800-635-1167.

Newsletter

Sign up for our newsletter to get the latest info.